Literature DB >> 28832796

Transverse Sternal Split: a Safe Mini-invasive Approach for Perventricular Device Closure of Ventricular Septal Defect.

Pankaj Garg1, Arvind Kumar Bishnoi1, Ketav Lakhia2, Jigar Surti3, Sumbul Siddiqui1, Parth Solanki2, Himani Pandya3.   

Abstract

OBJECTIVE: : Perventricular device closure of ventricular septal defect through midline sternotomy avoids the cardiopulmonary bypass, however, lacks the cosmetic advantage. Perventricular device closure of ventricular septal defect with transverse split sternotomy was performed to add the cosmetic advantage of mini-invasive technique.
METHODS: : Thirty-six pediatric patients with mean age 7.14±3.24 months and weight 5.00±0.88 kg were operated for perventricular device closure of ventricular septal defect through transverse split sternotomy in 4th intercostal space under transesophageal echocardiography guidance. In case of failure or complication, surgical closure of ventricular septal defect was performed through the same incision with cervical cannulation of common carotid artery and internal jugular vein for commencement of cardiopulmonary bypass. All the patients were postoperatively followed, and then discharged from hospital due to their surgical outcome, morbidity and mortality.
RESULTS: : Procedure was successful in 35 patients. Two patients developed transient heart block. Surgical closure of ventricular septal defect was required in one patient. Mean duration of ventilation was 11.83±3.63 hours. Mean intensive care unit and hospital stay were 1.88±0.74 days and 6.58±1.38 days, respectively. There was no in-hospital mortality. A patient died one day after hospital discharge due to arrhythmia. No patients developed wound related, vascular or neurological complication. In a mean follow-up period of 23.3±18.45 months, all 35 patients were doing well without residual defect with regression of pulmonary artery hypertension as seen on transthoracic echocardiography.
CONCLUSION: : Transverse split sternotomy incision is a safe and effective alternative to a median sternotomy for perventricular device closure of ventricular septal defect with combined advantage of better cosmetic outcomes and avoidance of cardiopulmonary bypass.

Entities:  

Mesh:

Year:  2017        PMID: 28832796      PMCID: PMC5570392          DOI: 10.21470/1678-9741-2016-0041

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  23 in total

1.  Analysis of 14,843 neonatal congenital heart surgical procedures in the European Association for Cardiothoracic Surgery Congenital Database.

Authors:  Andrzej Kansy; Zdzislaw Tobota; Przemyslaw Maruszewski; Bohdan Maruszewski
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

2.  Perventricular device closure of muscular ventricular septal defects on beating hearts: initial experience in eight children.

Authors:  Changping Gan; Ke Lin; Qi An; Hong Tang; Haibo Song; Raphael C Lui; Kaiyu Tao; Zhongyun Zhuang; Yingkang Shi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-12-19       Impact factor: 5.209

Review 3.  Closure of muscular ventricular septal defects: Transcatheter and hybrid techniques.

Authors:  Zahid Amin; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2008-07-01       Impact factor: 2.692

4.  Minimally invasive perventricular device closure of ventricular septal defect: a comparative study in 80 patients.

Authors:  Xin-Chao Yang; De-Bin Liu
Journal:  Chin Med Sci J       Date:  2014-06

Review 5.  A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD).

Authors:  Linqi Yang; Bee-Choo Tai; Lay Wai Khin; Swee Chye Quek
Journal:  J Interv Cardiol       Date:  2014-04-29       Impact factor: 2.279

6.  Transthoracic device closure of ventricular septal defects without cardiopulmonary bypass: experience in infants weighting less than 8 kg.

Authors:  Quansheng Xing; Qin Wu; Silin Pan; Yueyi Ren; Hao Wan
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-04       Impact factor: 4.191

7.  Mid-term follow up of perventricular device closure of muscular ventricular septal defects.

Authors:  Edgard A Bendaly; Mark H Hoyer; John P Breinholt
Journal:  Catheter Cardiovasc Interv       Date:  2011-06-09       Impact factor: 2.692

8.  Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results.

Authors:  Emile A Bacha; Qi-Ling Cao; Joanne P Starr; David Waight; Makram R Ebeid; Ziyad M Hijazi
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

9.  Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: feasibility and outcome.

Authors:  Karim A Diab; Qi-Ling Cao; Bassem N Mora; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2007-07-01       Impact factor: 2.692

10.  Complete heart block associated with device closure of perimembranous ventricular septal defects.

Authors:  Dragos Predescu; Rajiv R Chaturvedi; Mark K Friedberg; Lee N Benson; Akira Ozawa; Kyong-Jin Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2008-06-06       Impact factor: 5.209

View more
  1 in total

1.  Anterior Minithoracotomy: a Safe Approach for Surgical ASD Closure & ASD Device Retrieval.

Authors:  Vivek Wadhawa; Chirag Doshi; Manish Hinduja; Pankaj Garg; Kartik Patel; Amit Mishra; Pratik Shah
Journal:  Braz J Cardiovasc Surg       Date:  2017 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.